Quality Of Life While Receiving Faslodex

Inclusion Criteria

• - Histologic and/or cytological proven breast cancer.
• - Patients with metastases of breast cancer ± postmenopausal primary tumor ≥12 months.
• - Positive oestrogen receptors (ER+), positive progesterone receptors (PgR+) or unknown hormonal receptors (if duration between surgery and metastasis occurring is not less 2 years) which are indirect confirmation of hormone sensitive tumor.
• - ECOG performance status of ≤ 2
• - Patient willingness to take part in the programm
• - Life expectancy of more than 6 months.
• - Patient ability to complete a questionnaire.